{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:24:15Z","timestamp":1790745855531,"version":"4.1.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,16]],"date-time":"2019-02-16T00:00:00Z","timestamp":1550275200000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.imlet.2017.09.007","type":"journal-article","created":{"date-parts":[[2017,9,15]],"date-time":"2017-09-15T17:47:10Z","timestamp":1505497630000},"page":"61-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Is there a role for IL-17 in the pathogenesis of systemic sclerosis?"],"prefix":"10.1016","volume":"195","author":[{"given":"Carlo","family":"Chizzolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra Maria","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00f2 Costantino","family":"Brembilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.imlet.2017.09.007_bib0005","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.imlet.2017.09.007_bib0010","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.autrev.2010.09.016","article-title":"Fibrosis and immune dysregulation in systemic sclerosis","volume":"10","author":"Chizzolini","year":"2011","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.imlet.2017.09.007_bib0015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.autrev.2010.09.015","article-title":"Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy","volume":"10","author":"Wei","year":"2011","journal-title":"Autoimmun. Rev."},{"issue":"12","key":"10.1016\/j.imlet.2017.09.007_bib0020","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1002\/art.24038","article-title":"Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis","volume":"58","author":"Koenig","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.imlet.2017.09.007_bib0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/path.1711660307","article-title":"Sequential dermal microvascular and perivascular changes in the development of scleroderma","volume":"166","author":"Prescott","year":"1992","journal-title":"J. Pathol."},{"issue":"5","key":"10.1016\/j.imlet.2017.09.007_bib0030","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00281-015-0509-1","article-title":"The role of the acquired immune response in systemic sclerosis","volume":"37","author":"Chizzolini","year":"2015","journal-title":"Semin. Immunopathol."},{"issue":"1","key":"10.1016\/j.imlet.2017.09.007_bib0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2362.1988.tb01158.x","article-title":"Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization","volume":"18","author":"Scharffetter","year":"1988","journal-title":"Eur. J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.imlet.2017.09.007_bib0040","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.4049\/jimmunol.168.7.3649","article-title":"Oligoclonal T cell expansion in the skin of patients with systemic sclerosis","volume":"168","author":"Sakkas","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.09.007_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2017.05.004","article-title":"Unfolding the pathogenesis of scleroderma through genomics and epigenomics","author":"Tsou","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imlet.2017.09.007_bib0050","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.mam.2016.10.001","article-title":"Epigenetics in fibrosis","volume":"54","author":"O'Reilly","year":"2017","journal-title":"Mol. Aspects Med."},{"issue":"24","key":"10.1016\/j.imlet.2017.09.007_bib0055","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"van Laar","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.imlet.2017.09.007_bib0060","first-page":"S4","article-title":"Cell-type specific gene expression analysis of early systemic sclerosis skin shows a prominent activation pattern of innate and adaptive immune system","author":"Assassi","year":"2017","journal-title":"J. Scleroderma Relat. Disord."},{"issue":"6","key":"10.1016\/j.imlet.2017.09.007_bib0065","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/ni.3742","article-title":"Interleukin 17 is a chief orchestrator of immunity","volume":"18","author":"Veldhoen","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2017.09.007_bib0070","series-title":"Cold Spring Harbor Perspectives in Biology","article-title":"Interleukin 17 family cytokines: signaling mechanisms, biological activities, and therapeutic implications","author":"Monin","year":"2017"},{"issue":"3","key":"10.1016\/j.imlet.2017.09.007_bib0075","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1189\/jlb.3HI1215-542R","article-title":"Human mast cells capture, store, and release bioactive, exogenous IL-17A","volume":"100","author":"Noordenbos","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.imlet.2017.09.007_bib0080","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.15358","article-title":"IL-17A localizes in the exocytic compartment of mast cells in psoriatic skin","author":"Brembilla","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.imlet.2017.09.007_bib0085","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imlet.2017.09.007_bib0090","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nri2433","article-title":"Cytokine-mediated regulation of antimicrobial proteins","volume":"11","author":"Kolls","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2017.09.007_bib0095","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.immuni.2008.07.018","article-title":"Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction","volume":"29","author":"Ogura","year":"2008","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.imlet.2017.09.007_bib0100","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1002\/art.21342","article-title":"Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis","volume":"52","author":"Koenders","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.imlet.2017.09.007_bib0105","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1242\/dmm.012062","article-title":"Diverse functions of matrix metalloproteinases during fibrosis","volume":"7","author":"Giannandrea","year":"2014","journal-title":"Dis. Models Mechan."},{"issue":"5","key":"10.1016\/j.imlet.2017.09.007_bib0110","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1165\/rcmb.2015-0020TR","article-title":"Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis","volume":"53","author":"Craig","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.imlet.2017.09.007_bib0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.matbio.2015.03.002","article-title":"Matrix remodeling by MMPs during wound repair","volume":"44\u201346","author":"Rohani","year":"2015","journal-title":"Matrix Biol."},{"issue":"9","key":"10.1016\/j.imlet.2017.09.007_bib0120","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1182\/blood-2008-05-155408","article-title":"Prostaglandin E2 (PGE2) synergistically with interleukin-23 (IL-23) favors human Th17 expansion","volume":"112","author":"Chizzolini","year":"2008","journal-title":"Blood"},{"issue":"5969","key":"10.1016\/j.imlet.2017.09.007_bib0125","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1178334","article-title":"Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells","volume":"327","author":"O'Shea","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.imlet.2017.09.007_bib0130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imlet.2017.09.007_bib0135","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4T cell populations (*)","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.imlet.2017.09.007_bib0140","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.imlet.2017.09.007_bib0145","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2017.09.007_bib0150","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells","volume":"24","author":"Veldhoen","year":"2006","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.imlet.2017.09.007_bib0155","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"issue":"7318","key":"10.1016\/j.imlet.2017.09.007_bib0160","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature09447","article-title":"Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling","volume":"467","author":"Ghoreschi","year":"2010","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.imlet.2017.09.007_bib0165","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.4049\/jimmunol.175.7.4184","article-title":"Cutting edge: activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin generates a population of CD4+ CD25+ cells with characteristics of regulatory T cells","volume":"175","author":"Funatake","year":"2005","journal-title":"J. Immunol."},{"issue":"7191","key":"10.1016\/j.imlet.2017.09.007_bib0170","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature06880","article-title":"Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor","volume":"453","author":"Quintana","year":"2008","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.imlet.2017.09.007_bib0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1084\/jem.20081438","article-title":"Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17T cells","volume":"206","author":"Veldhoen","year":"2009","journal-title":"J. Exp. Med."},{"issue":"13","key":"10.1016\/j.imlet.2017.09.007_bib0180","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.1073\/pnas.0911755107","article-title":"Notch signaling drives IL-22 secretion in CD4+ T cells by stimulating the aryl hydrocarbon receptor","volume":"107","author":"Alam","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.imlet.2017.09.007_bib0185","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1002\/eji.201040461","article-title":"Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells","volume":"40","author":"Ramirez","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.imlet.2017.09.007_bib0190","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/ni.1770","article-title":"Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells","volume":"10","author":"Trifari","year":"2009","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.imlet.2017.09.007_bib0195","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri3707","article-title":"The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2017.09.007_bib0200","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ni1467","article-title":"Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2017.09.007_bib0205","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20082293","article-title":"Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2\/EP4 receptor signaling","volume":"206","author":"Boniface","year":"2009","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.imlet.2017.09.007_bib0210","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1002\/eji.200838969","article-title":"Prostaglandin E2 enhances Th17 responses via modulation of IL-17 and IFN-gamma production by memory CD4+ T cells","volume":"39","author":"Napolitani","year":"2009","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2017.09.007_bib0215","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/ar3486","article-title":"Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease","volume":"13","author":"Truchetet","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.imlet.2017.09.007_bib0220","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.autrev.2013.12.004","article-title":"Th17 and regulatory T cell balance in autoimmune and inflammatory diseases","volume":"13","author":"Noack","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.imlet.2017.09.007_bib0225","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.cell.2011.07.033","article-title":"Control of T(H)17\/T(reg) balance by hypoxia-inducible factor 1","volume":"146","author":"Dang","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2017.09.007_bib0230","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fimmu.2017.00417","article-title":"The microbiota and epigenetic regulation of t helper 17\/Regulatory t cells: In search of a balanced immune system","volume":"8","author":"Luo","year":"2017","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2017.09.007_bib0235","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1172\/JCI37865","article-title":"Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD\/SCID recipient mice","volume":"119","author":"Bending","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"7395","key":"10.1016\/j.imlet.2017.09.007_bib0240","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature10957","article-title":"Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta","volume":"484","author":"Zielinski","year":"2012","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.imlet.2017.09.007_bib0245","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1684\/ecn.2013.0325","article-title":"T cell abnormalities in systemic sclerosis with a focus on Th17 cells","volume":"23","author":"Brembilla","year":"2012","journal-title":"Eur. Cytokine Netw."},{"issue":"6","key":"10.1016\/j.imlet.2017.09.007_bib0250","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/08916934.2015.1037441","article-title":"Interleukin-17 in systemic lupus erythematosus: a comprehensive review","volume":"48","author":"Li","year":"2015","journal-title":"Autoimmunity"},{"issue":"7","key":"10.1016\/j.imlet.2017.09.007_bib0255","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6070065","article-title":"T helper 17 cells in primary Sjogren's syndrome","volume":"6","author":"Matsui","year":"2017","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.imlet.2017.09.007_bib0260","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00281-017-0619-z","article-title":"Selected cytokine pathways in rheumatoid arthritis","volume":"39","author":"Noack","year":"2017","journal-title":"Semin. Immunopathol."},{"issue":"11","key":"10.1016\/j.imlet.2017.09.007_bib0265","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K","article-title":"Increased interleukin-17 production in patients with systemic sclerosis","volume":"43","author":"Kurasawa","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.imlet.2017.09.007_bib0270","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jdermsci.2008.01.001","article-title":"Clinical association of serum interleukin-17 levels in systemic sclerosis: is systemic sclerosis a Th17 disease?","volume":"50","author":"Murata","year":"2008","journal-title":"J. Dermatol. Sci."},{"issue":"8","key":"10.1016\/j.imlet.2017.09.007_bib0275","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.4049\/jimmunol.1100591","article-title":"Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts","volume":"188","author":"Nakashima","year":"2012","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2017.09.007_bib0280","doi-asserted-by":"crossref","first-page":"046013","DOI":"10.1088\/1752-7155\/10\/4\/046013","article-title":"Th-17 cytokines and interstitial lung involvement in systemic sclerosis","volume":"10","author":"Rolla","year":"2016","journal-title":"J. Breath Res."},{"issue":"12","key":"10.1016\/j.imlet.2017.09.007_bib0285","doi-asserted-by":"crossref","first-page":"e85032","DOI":"10.1371\/journal.pone.0085032","article-title":"IL-17A induces endothelial inflammation in systemic sclerosis via the ERK signaling pathway","volume":"8","author":"Xing","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.imlet.2017.09.007_bib0290","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1756-185X.2011.01654.x","article-title":"Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients","volume":"15","author":"Higgs","year":"2012","journal-title":"Int. J. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.imlet.2017.09.007_bib0295","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1186\/ar2821","article-title":"Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations","volume":"11","author":"Gourh","year":"2009","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.imlet.2017.09.007_bib0300","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/1756-185X.12290","article-title":"Interleukin-and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis","volume":"17","author":"Olewicz-Gawlik","year":"2014","journal-title":"Int. J. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.imlet.2017.09.007_bib0305","first-page":"44","article-title":"IL-17, IL-6 and IFN-gamma in systemic sclerosis patients","volume":"53","author":"Balanescu","year":"2015","journal-title":"Rom. J. Intern. Med."},{"issue":"6","key":"10.1016\/j.imlet.2017.09.007_bib0310","doi-asserted-by":"crossref","first-page":"e5903","DOI":"10.1371\/journal.pone.0005903","article-title":"The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes","volume":"4","author":"Radstake","year":"2009","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.imlet.2017.09.007_bib0315","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.clim.2011.01.013","article-title":"Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis","volume":"139","author":"Fenoglio","year":"2011","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2017.09.007_bib0320","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/03009742.2010.528021","article-title":"Altered T-cell and regulatory cell repertoire in patients with diffuse cutaneous systemic sclerosis","volume":"40","author":"Papp","year":"2011","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.imlet.2017.09.007_bib0325","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s00296-011-2056-y","article-title":"Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study","volume":"32","author":"Rodriguez-Reyna","year":"2011","journal-title":"Rheumatol. Int."},{"issue":"6","key":"10.1016\/j.imlet.2017.09.007_bib0330","doi-asserted-by":"crossref","first-page":"e64531","DOI":"10.1371\/journal.pone.0064531","article-title":"Elevated levels of CD4(+)CD25(+)FoxP3(+) T cells in systemic sclerosis patients contribute to the secretion of IL-17 and immunosuppression dysfunction","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.imlet.2017.09.007_bib0335","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000450949","article-title":"Disease manifestation and inflammatory activity as modulators of Th17\/Treg balance and RORC\/FoxP3 methylation in systemic sclerosis","volume":"171","author":"Almanzar","year":"2016","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.imlet.2017.09.007_bib0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2017.04.013","article-title":"IL-10-producing regulatory B cells (B10 cells), IL-17+ T cells and autoantibodies in systemic sclerosis","author":"Mavropoulos","year":"2017","journal-title":"Clin. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2017.09.007_bib0345","first-page":"765","article-title":"Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis","volume":"27","author":"Meloni","year":"2009","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.imlet.2017.09.007_bib0350","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/art.30159","article-title":"Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension","volume":"63","author":"Hsu","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.imlet.2017.09.007_bib0355","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/art.37860","article-title":"Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement","volume":"65","author":"Truchetet","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.imlet.2017.09.007_bib0360","doi-asserted-by":"crossref","first-page":"e105008","DOI":"10.1371\/journal.pone.0105008","article-title":"High IL-17E and low IL-17C dermal expression identifies a fibrosis-Specific motif common to morphea and systemic sclerosis","volume":"9","author":"Lonati","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.imlet.2017.09.007_bib0365","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/ar4430","article-title":"Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction","volume":"16","author":"Yang","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.imlet.2017.09.007_bib0370","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.humimm.2014.12.008","article-title":"The elevated expression of Th17-related cytokines and receptors is associated with skin lesion severity in early systemic sclerosis","volume":"76","author":"Zhou","year":"2015","journal-title":"Hum. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2017.09.007_bib0375","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/ard.60.6.592","article-title":"European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes","volume":"60","author":"Valentini","year":"2001","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.imlet.2017.09.007_bib0380","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1186\/ar4334","article-title":"Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts","volume":"15","author":"Brembilla","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.imlet.2017.09.007_bib0385","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1186\/s13075-014-0512-2","article-title":"Interleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular-regulated protein kinases signalling pathway","volume":"16","author":"Liu","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2017.09.007_bib0390","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1136\/annrheumdis-2012-201400","article-title":"Prostaglandin I2 analogues enhance already exuberant Th17 cell responses in systemic sclerosis","volume":"71","author":"Truchetet","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.imlet.2017.09.007_bib0395","first-page":"1830","article-title":"Low versus high-dose iloprost therapy over 21 days in patients with secondary raynaud's phenomenon and systemic sclerosis: a randomized, open, single-center study","volume":"35","author":"Kawald","year":"2008","journal-title":"J. Rheumatol."},{"issue":"6","key":"10.1016\/j.imlet.2017.09.007_bib0400","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","article-title":"T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines","volume":"183","author":"Fossiez","year":"1996","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.imlet.2017.09.007_bib0405","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00002281-200111000-00010","article-title":"Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis","volume":"13","author":"Denton","year":"2001","journal-title":"Curr. Opin. Rheumatol."},{"issue":"1","key":"10.1016\/j.imlet.2017.09.007_bib0410","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/art.1780350111","article-title":"Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma","volume":"35","author":"Needleman","year":"1992","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.imlet.2017.09.007_bib0415","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2249.2004.02642.x","article-title":"Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement","volume":"138","author":"Scala","year":"2004","journal-title":"Clin. Exp. Immunol."},{"issue":"5\u20136","key":"10.1016\/j.imlet.2017.09.007_bib0420","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000163802","article-title":"In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease","volume":"61","author":"Koch","year":"1993","journal-title":"Pathobiology"},{"issue":"2","key":"10.1016\/j.imlet.2017.09.007_bib0425","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0923-1811(01)00128-1","article-title":"Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis","volume":"27","author":"Sato","year":"2001","journal-title":"J. Dermatol. Sci."},{"issue":"1","key":"10.1016\/j.imlet.2017.09.007_bib0430","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13075-016-0993-2","article-title":"Frequency of circulating topoisomerase-I-specific CD4 T cells predicts presence and progression of interstitial lung disease in scleroderma","volume":"18","author":"Fava","year":"2016","journal-title":"Arthritis Res. Ther."},{"issue":"12","key":"10.1016\/j.imlet.2017.09.007_bib0435","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.3899\/jrheum.090421","article-title":"Association of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosis","volume":"36","author":"Agarwal","year":"2009","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.imlet.2017.09.007_bib0440","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/ard.2008.096719","article-title":"The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype","volume":"68","author":"Rueda","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.imlet.2017.09.007_bib0445","doi-asserted-by":"crossref","first-page":"657","DOI":"10.4049\/jimmunol.182.1.657","article-title":"Th17-polarized immune response in a murine model of hypersensitivity pneumonitis and lung fibrosis","volume":"182","author":"Simonian","year":"2009","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2017.09.007_bib0450","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20092121","article-title":"Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent","volume":"207","author":"Wilson","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2017.09.007_bib0455","doi-asserted-by":"crossref","DOI":"10.1002\/art.34643","article-title":"Potential roles of interleukin 17A in the development of skin fibrosis","author":"Okamoto","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.imlet.2017.09.007_bib0460","doi-asserted-by":"crossref","first-page":"e23185","DOI":"10.1371\/journal.pone.0023185","article-title":"IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis","volume":"6","author":"Gasse","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.imlet.2017.09.007_bib0465","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.4049\/jimmunol.1004081","article-title":"Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and \u2212independent mechanisms","volume":"187","author":"Mi","year":"2011","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2017.09.007_bib0470","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ni1552","article-title":"Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice","volume":"9","author":"Hsu","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2017.09.007_bib0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2017.07.019","article-title":"Role of anti-Receptor autoantibodies in pathophysiology of scleroderma","author":"Berger","year":"2017","journal-title":"Autoimmun. Rev."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817304261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817304261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:34:26Z","timestamp":1759044866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247817304261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":95,"alternative-id":["S0165247817304261"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2017.09.007","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is there a role for IL-17 in the pathogenesis of systemic sclerosis?","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2017.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}